沸腾了！“牛市旗手”，全面爆发！

Market Overview - The A-share market showed a rising trend on August 13, with the Shanghai Composite Index up by 0.56%, the Shenzhen Component Index up by 1.47%, and the ChiNext Index up by 2.81% [3][4]. Sector Performance - Broker stocks experienced significant upward movement, with notable gains in the innovative drug sector, as well as active performances in communication equipment, semiconductors, and precious metals. Conversely, sectors such as agriculture, ports, and textiles showed signs of adjustment [5][6]. Broker Stocks - Broker stocks saw a sharp rise, with Changcheng Securities hitting the daily limit, Guosheng Financial achieving two consecutive limits, and Dongwu Securities, Bank of China Securities, and Huatai Securities all rising over 5% [10][12]. - Specific stock performances included: - Changcheng Securities: 10.06% increase, total market value of 40.2 billion - Guosheng Financial: 9.98% increase, total market value of 37.8 billion - Dongwu Securities: 8.00% increase, total market value of 51.6 billion [11]. Innovative Drug Sector - The innovative drug sector also saw significant gains, with Shouyao Holdings reaching a 20% limit, and Haizike also hitting the limit. Other companies like Meidi West, Zhaoyan New Drug, and Kailai Ying followed suit with notable increases [14][17]. - Key stock performances included: - Shouyao Holdings: 19.99% increase, total market value of 8.3 billion - Meidi West: 10.68% increase, total market value of 87.17 billion - Zhaoyan New Drug: 8.52% increase, total market value of 24.11 billion [16]. Policy Impact - The National Healthcare Security Administration recently announced the preliminary review results for the 2025 medical insurance directory and the commercial insurance innovative drug directory, with 534 drugs passing the basic medical insurance directory review and 121 drugs passing the commercial insurance innovative drug directory review [17].